2-amino-3-methylimidazo(4,5-f)quinoline has been researched along with transforming growth factor alpha in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Davis, CD; Santoni-Rugiu, E; Snyderwine, EG; Thorgeirsson, SS | 1 |
Ryu, DY; Snyderwine, EG; Thorgeirsson, SS; Weidner, V | 1 |
2 other study(ies) available for 2-amino-3-methylimidazo(4,5-f)quinoline and transforming growth factor alpha
Article | Year |
---|---|
Hepatic tumor induction in c-myc mono-transgenic and TGF-alpha/c-myc double-transgenic mice.
Topics: Animals; Carcinogens; Diethylnitrosamine; Liver Neoplasms, Experimental; Mice; Mice, Transgenic; Phenobarbital; Proto-Oncogene Proteins c-myc; Quinolines; Transforming Growth Factor alpha | 1997 |
Carcinogenicity and mutagenicity of heterocyclic amines in transgenic mouse models.
Topics: Animals; DNA, Complementary; Genes, myc; Mice; Mice, Transgenic; Mutagenesis; Mutagens; Neoplasms, Experimental; Quinolines; Quinoxalines; Transforming Growth Factor alpha | 1999 |